Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
Kidney: Novel Immunosuppressant Strategies
Wednesday August 06, 2025 - 10:00 to 11:15
Room: 155
60.5 Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up
Log in to add to favorites
Add Personal Notes
Ashley Vo, United States
Presentations by Ashley Vo
Wed-06 from 10:00 - 11:15 in room 155
Kidney: Novel Immunosuppressant Strategies
Daratumumab (Anti-CD38) Desensitization in HLA Sensitized Patients: Long-Term Follow-Up
Email:
info@wtc2025.org
514-874-1717
